A 5-year-old girl presented with a history of global developmental delay and recurrent focal seizures since 2 years of age. Her parents had also noticed a progressive abdominal distension for the last 1 year.

Physical examination revealed facial angiofibroma/adenoma sebaceum ([Figure 1](#fig1){ref-type="fig"}), blood pressure of 110/80 mmHg (between the 95th and 99th percentiles for age sex and height percentile) and a soft but distended abdomen with bilaterally palpable kidneys.
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Her laboratory investigations were unremarkable, and she had no proteinuria, microscopic haematuria or renal dysfunction. Imaging studies showed a bilateral nephromegaly with multiple cysts on ultrasonography ([Figure 2](#fig2){ref-type="fig"}) and periventricular tubers on computed tomography scan of the brain ([Figure 3](#fig3){ref-type="fig"}).
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![Computed tomography of the brain showing periventricular tubers (arrows).](sfq045fig3){#fig3}

In view of the presence of features of both autosomal dominant polycystic kidney disease (enlarged kidneys with multiple cysts) as well as tuberous sclerosis (facial angiofibroma/adenoma sebaceum and periventricular tubers) but absent family history of renal diseases and normal screening parental ultrasound, a clinical diagnosis of polycystic kidney disease 1/tuberous sclerosis complex 2 (*TSC2*) contiguous gene syndromes (PKDTS) was made.

*TSC2* (located at 16p13.3) and *PKD1* (16p13.3) genes lie immediately adjacent to each other in a tail-to-tail configuration with \~3 kb of genomic DNA in the intergenic region \[[@ref1]\]. Mutation analysis has shown that 2--3% of *TSC2* mutations are large genomic DNA deletions in which some part of both *TSC2* and *PKD1* are involved \[[@ref2]\], leading to a novel contiguous gene syndrome PKDTS (Mendelian Inheritance of Mankind: 600273).

In contrast with the typical TSC, the renal lesion in the PKDTS consists of PKD, which has an earlier onset and progresses more rapidly \[[@ref3]\]. This feature of PKDTS also contrasts with isolated ADPKD, where onset is usually later and progression slower.

To conclude, PKDTS is a distinct clinical entity and should be considered in patients with an early manifestation of PKD without a positive family history, but having clinical features of TSC.
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